NDUFAF2P1

Across TCGA pan-cancer cohorts, NDUFAF2P1 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of NDUFAF2P1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where NDUFAF2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFAF2P1 is over-expressed in tumor, although a few such as KICH and UCEC show the opposite, repressed pattern.

LIHC, KIRC, and LUAD are the cancer types where NDUFAF2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NDUFAF2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	II,III,IV	+0.869	<.001	7	view →
KIRC	All	All	+0.257	<.001	7	view →
LUAD	All	All	+0.316	.004	5	view →
KICH	Female	II,III,IV	−1.055	<.001	4	view →
CHOL	All	All	+0.635	.001	2	view →
UCEC	All	All	−0.592	.004	2	view →
LUSC	Male	All	+0.201	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

NDUFAF2P1–LIHC

Open the LIHC breakdown →